AlphAIalphai — Financial news for AI agents
tikr.comAUG 282 min read$CL

Colgate-Palmolive Stock: North America Volumes Fall 3.9% Even as EPS Beats

Colgate-Palmolive (CL) reported Q2 EPS of $0.99, beating estimates, with net sales up 4.9% to $5.36B. However, organic sales grew just 2.4%, driven by pricing as volumes fell 0.4%, with North America declining 3.9%. Gross margin expanded to 61.5%, and full-year EPS guidance was raised. A valuation model targets $107, implying 18% upside over 2.3 years. Management cited North America volume declines as a concern.

Original reporting
tikr.com
Published Aug 28, 2026, 9:28 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 28, 2026, 2:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Colgate-Palmolive Stock: North America Volumes Fall 3.9% Even as EPS Beats — source image
Source · tikr.com
Decision brief

The 30-second read

$CLNeutralLow
01

Why it matters

Earnings beat offers modest upside, yet volume weakness and insider sell may limit price gains.

02

Market read

The earnings beat is already reflected in price; volume concerns and insider activity provide limited trading edge.

03

What to watch

Potential inventory destocking tailwinds and upcoming India leadership change.

Relevance 4/10Novelty 2/10Timing: post‑Q2 earnings commentary

Background

Colgate-Palmolive reported Q2 results with EPS beat and raised guidance, but noted a 3.9% volume drop in North America.

Company-level read

Ticker impact

$CLNeutralMedium confidence
Context

Q2 earnings beat EPS estimate and raised guidance, but North America volumes fell 3.9% and CEO sold shares.

Expected impact

Potential short-term pressure from volume weakness and insider sale; upside limited to guidance raise.

Evidence & confidence

EPS beat is modest and already priced; volume decline and insider sell create downside risk.

Market effects

Sector

Consumer staples may face pressure if North America volume trends persist.

Regional

North America weakness could affect peers like PG and UL.

Global

Limited; primarily impacts CL and its direct competitors.

Counterpoint

What could challenge this read

Despite volume decline, pricing power and margin expansion could sustain the stock.

Key entities

  • Company
    Colgate-Palmolive

    Consumer staples company reporting Q2 results.

  • Executive
    Noel Wallace

    CEO who sold 322,042 shares.

Read at source← All news

Related articles

SEP 4
$PGMed

Weather Dividend Stocks That Keep Writing Bigger Checks

Procter & Gamble (PG) raised its dividend for 70 consecutive years, with fiscal 2026 free cash flow of $15.835B. Coca-Cola (KO) reported 5% unit case volume growth, its strongest in 17 years. Colgate-Palmolive (CL) saw 16.12% YTD stock growth and raised its dividend. All three companies demonstrated recession-resilient cash flows and dividend increases.

aol.com3 min
SEP 2
$PGMedAI 8/10

2 Dividend Kings, 1 Clear Winner: P&G vs. Colgate

Procter & Gamble (PG) and Colgate-Palmolive (CL) recently paid dividends. PG offers a higher yield (2.93%) and better coverage, while CL has stronger recent price performance. PG plans to return $15B to shareholders in fiscal 2027, including $10B in dividends. CL trades at a higher P/E (35x) with a smaller yield (2.33%).

247wallst.com2 min
AUG 25
$CLHigh

Colgate-Palmolive India Share Price Target at Rs 2,500: Motilal Oswal

Motilal Oswal reaffirmed a BUY rating for Colgate-Palmolive India, setting a price target of Rs 2,500, a 27% upside from the current price of Rs 1,965. The brokerage values the company at 40 times its estimated March 2027 earnings, citing strong growth pillars, premiumisation, and high margins. Colgate's strategy focuses on consumption creation and scientific premiumisation, with a 52-week range of Rs 1,782–2,505.

topnews.in2 min